OVER / UNDER
KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATECMPS-360 ★ KALSHI ★ MULTI ★

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Price history — Before 2028

Last 7 days of market YES price (blue) with the fair-price range (orange).

84¢0¢25¢50¢75¢100¢Wed 5/20Thu 5/21Fri 5/22Sat 5/23Sun 5/24Mon 5/25TODAY
━ market YES▬ fair range
Market price
Before 2028★ BEST84¢
Before October 202777¢
Before July 202769¢
Before Mar 1, 202740¢
Before Jan 1, 202717¢
Kalshi • Volume: 8.9K contracts • Updated 30m agoCloses: 2028-01-01
Kalshi · Science and Technology
OU's Pick
YES · Before 2028
at 84¢
Price gap
Kalshi84¢
→
OU's fair85¢
+1¢ underpriced · pays 1.2×
Confidence
Moderate

Compass Pathways targets a rolling NDA submission in late 2026 which makes an FDA approval decision highly probable by the end of 2027.

Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.